[144] Bankwell Financial Group Inc SEC Filing

Rhea-AI Filing Summary

Bankwell Financial Group, Inc. (BWFG) – Form 144 filing discloses a proposed sale of restricted shares under SEC Rule 144.

• Securities to be sold: 389 common shares
• Approximate market value: $14,231.84 (based on filing data)
• Percentage of shares outstanding: roughly 0.005% of the 7,873,387 shares outstanding
• Broker: Georgeson Securities Corporation, Edison, NJ
• Planned sale date: 01 July 2025 on NASDAQ
• Acquisition source: Restricted-stock vesting from Bankwell Financial Group on 01 July 2025, involving 834 shares received for services rendered

No prior sales were reported during the past three months. The filer certifies awareness of no undisclosed material adverse information. Given the small size of the transaction relative to total shares outstanding and lack of additional context (e.g., officer/director identity, recurring sales), this notice is typically viewed as an administrative disclosure rather than a catalyst for material valuation change.

Insights

Financial Analyst

TL;DR: Very small insider sale (389 shares, <0.01% float); likely immaterial to valuation or sentiment.

The Form 144 indicates intent to sell 389 BWFG common shares worth about $14k. Against a market cap that presumably exceeds $200 million, the sale is negligible. No pattern of prior sales appears, and the shares stem from recent restricted-stock vesting, suggesting portfolio diversification rather than a bearish signal. Absent earnings or strategic news, the filing should not influence price discovery.

Corporate Governance Expert

TL;DR: Routine Rule 144 notice; complies with disclosure rules, minimal governance implications.

Rule 144 requires insiders to file when selling restricted or control securities. The filer certifies no undisclosed adverse information, and no aggregation issues arose under Rule 144(e). With no additional sales in the past quarter and an extremely small stake relative to float, the notice reflects standard compliance. Governance risk remains unchanged.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Georgeson Securities Corporation 144 Fernwood Ave Edison NJ 08837	389	14231.84	7873387	07/01/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Class	07/01/2025	Restricted Stock Vesting	Bankwell Financial Group, Inc.			834	07/01/2025	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Bankwell Financial Group (BWFG) shares are being sold under this Form 144?

The filing covers 389 common shares to be sold.

What is the market value of the BWFG shares to be sold?

The aggregate market value disclosed is approximately $14,231.84.

When is the planned sale date for the BWFG shares?

The filer intends to sell on 01 July 2025.

What percentage of Bankwell Financial Group’s outstanding shares does this sale represent?

About 0.005% of the 7,873,387 shares outstanding.

Why was a Form 144 filed?

Form 144 is required when insiders propose to sell restricted or control securities under SEC Rule 144.

Who is the broker handling the transaction?

Georgeson Securities Corporation, Edison, NJ is listed as the broker.